| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/14796678.5.1.27 |
| P698 | PubMed publication ID | 19371201 |
| P2093 | author name string | Nuccia Morici | |
| Stefano Savonitto | |||
| Silvio Klugmann | |||
| Alice Sacco | |||
| P2860 | cites work | Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction | Q22242900 |
| Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients | Q24555072 | ||
| Non-ST-elevation acute coronary syndrome in the elderly: treatment strategies and 30-day outcome | Q28168545 | ||
| Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban | Q28185502 | ||
| Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial | Q28185738 | ||
| Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation | Q28188284 | ||
| Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study | Q28190808 | ||
| Early invasive versus selectively invasive management for acute coronary syndromes | Q28191886 | ||
| Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials | Q28202129 | ||
| Bivalirudin for patients with acute coronary syndromes | Q28210982 | ||
| Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q28213459 | ||
| Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE) | Q28213517 | ||
| An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators | Q28254763 | ||
| Bivalirudin during primary PCI in acute myocardial infarction | Q28281179 | ||
| Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase | Q33447121 | ||
| Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention | Q33773917 | ||
| FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease | Q35584557 | ||
| The year in non-ST-segment elevation acute coronary syndrome | Q37291568 | ||
| Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial | Q38393483 | ||
| Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial | Q38408523 | ||
| Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials | Q40414100 | ||
| Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative | Q43590434 | ||
| The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes | Q43832639 | ||
| Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention | Q43993720 | ||
| Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes | Q44108434 | ||
| Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a r | Q44589935 | ||
| Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration | Q44618977 | ||
| Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention | Q44619428 | ||
| Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators. | Q44905594 | ||
| Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study | Q45291455 | ||
| Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators | Q45335057 | ||
| Bivalirudin versus unfractionated heparin during percutaneous coronary intervention | Q46429322 | ||
| New anticoagulants--the path from discovery to clinical practice | Q46519029 | ||
| Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes | Q46575028 | ||
| Impact of acute renal failure following percutaneous coronary intervention on long-term mortality | Q46707220 | ||
| Early aggressive vs. initially conservative treatment in elderly patients with non-ST-elevation acute coronary syndrome: the Italian Elderly ACS study. | Q46732793 | ||
| Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point | Q46750174 | ||
| Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome | Q46770154 | ||
| Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? | Q46891646 | ||
| Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation | Q46910098 | ||
| Prasugrel versus clopidogrel in patients with acute coronary syndromes | Q46915044 | ||
| Comparison of fondaparinux and enoxaparin in acute coronary syndromes | Q46990542 | ||
| Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). | Q47438826 | ||
| Percutaneous coronary intervention pharmacology: from a triangle to a square | Q47908798 | ||
| Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. | Q51758758 | ||
| Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. | Q53340933 | ||
| Prognostic Value of the Admission Electrocardiogram in Acute Coronary Syndromes | Q56944985 | ||
| Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006 | Q57243464 | ||
| Acute Coronary Care in the Elderly, Part I | Q57483864 | ||
| Implementation of Guidelines Improves the Standard of Care | Q58071441 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 27-41 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Future Cardiology | Q15765184 |
| P1476 | title | Target populations and relevant therapeutic end points to further improve outcomes in NSTEACS patients | |
| P478 | volume | 5 |
Search more.